Lamidac 100mg Tablet

2 DOSAGE & ADMINISTRATION, Adults: 300 mg daily, administered as either 150 mg twice daily or 300 mg once daily., Pediatric Patients Aged 3 Months and Older: Administered either once or twice daily. 2.1 Recommended Dosage for Adult Patients The recommended dosage of lamivudine in HIV-1-infected adults is 300 mg daily, administered as either 150 mg taken orally twice daily or 300 mg taken orally once daily with or without food. If lamivudine is administered to a patient infected with HIV-1 and HBV, the dosage indicated for HIV-1 therapy should be used as part of an appropriate combination regimen.

Directions from the U.S. FDA-approved label for Lamivudine — your doctor or pharmacist may advise differently.

Lamivudine is contraindicated in patients with a previous hypersensitivity reaction to lamivudine. Lamivudine is contraindicated in patients with previous hypersensitivity reaction to lamivudine.

Excerpt from the U.S. FDA-approved label for Lamivudine. Talk to a pharmacist or doctor before use.

Co-infected HIV-1/HBV Patients: Emergence of lamivudine-resistant HBV variants associated with lamivudine-containing antiretroviral regimens has been reported., Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues., Pancreatitis: Use with caution in pediatric patients with a history of pancreatitis or other significant risk factors for pancreatitis.

Warnings and precautions excerpt from the U.S. FDA-approved label for Lamivudine — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are discussed in other sections of the labeling: Exacerbations of hepatitis B., Lactic acidosis and severe hepatomegaly with steatosis., Pancreatitis., Immune reconstitution syndrome., The most common reported adverse reactions (incidence greater than or equal to 15%) in adults were headache, nausea, malaise and fatigue, nasal signs and symptoms, diarrhea, and cough., The most common reported…

Excerpt from the U.S. FDA-approved label for Lamivudine — not a complete list. Talk to a pharmacist or doctor about side effects.

4 brands · 2 makers in the NepalDoc catalog — see the full Lamivudine guide →

Store lamivudine tablets at 20° to 25°C (68° to 77° F);

Storage information from the U.S. FDA-approved label for Lamivudine.